However, in advanced cancer stages, Cav1 transitions to an oncogenic role and is frequently associated with increased cancer cell survival, drug resistance, and metastatic potential (Shatz and Liscovitch, 2008; van Golen, 2006). Here, CAV1 is linked to cancer.